Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adgyl Lifesciences is an India-based contract research organization and CDMO focused on discovery support, preclinical development, and early clinical-enabling services for pharmaceutical, biotechnology, biologics, and medical device clients. The company provides in vivo pharmacology, DMPK, toxicology, GLP safety assessment, bioanalysis, process chemistry, analytical chemistry, and CMC support rather than developing a proprietary therapeutic pipeline. Its facility traces its operating history to 1987 under prior corporate avatars, while the current legal entity was incorporated in 2018. Adgyl positions itself as one of India’s larger preclinical research facilities and emphasizes support for global regulatory submissions, including IND-enabling packages. The company appears to operate as an active private service provider in Bangalore and is also referenced by Eurofins Advinus as a partner laboratory.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adgyl Lifesciences.